Asia Pacific Endometriosis Treatment Market Size & Outlook
Related Markets
Asia Pacific endometriosis treatment market highlights
- The Asia Pacific endometriosis treatment market generated a revenue of USD 356.8 million in 2024.
- The market is expected to grow at a CAGR of 13.3% from 2025 to 2030.
- In terms of segment, hormone therapy was the largest revenue generating treatment type in 2024.
- Hormone Therapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 356.8 million |
| Market revenue in 2030 | USD 754.7 million |
| Growth rate | 13.3% (CAGR from 2025 to 2030) |
| Largest segment | Hormone therapy |
| Fastest growing segment | Hormone Therapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Medication, Hormone Therapy |
| Key market players worldwide | Bayer AG, Pfizer Inc, AbbVie Inc, AstraZeneca PLC, ObsEva SA, Teva Pharmaceutical Industries Ltd, Zydus Lifesciences, Eli Lilly and Co, Astellas Pharma Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.3% of the global endometriosis treatment market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 754.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endometriosis Treatment Market Scope
Endometriosis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ObsEva SA | View profile | 27 | Chemin des Aulx, 12, Plan-les-Ouates, Geneva, Switzerland, 1228 | https://www.obseva.com |
| Zydus Lifesciences | View profile | 10001+ | Ahmedabad, Gujarat, India, Asia | https://zyduslife.com/ |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Asia Pacific endometriosis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endometriosis treatment market will help companies and investors design strategic landscapes.
Hormone therapy was the largest segment with a revenue share of 89.46% in 2025. Horizon Databook has segmented the Asia Pacific endometriosis treatment market based on pain medication, hormone therapy covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Asia Pacific endometriosis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific endometriosis treatment market databook
-
Our clientele includes a mix of endometriosis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific endometriosis treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific endometriosis treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific endometriosis treatment market report size, by country, 2021-2033 (US$M)
Asia Pacific Endometriosis Treatment Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
